ATA Action, Author at ATA Action

ATA ACTION SUBMITS RECOMMENDATIONS TO DEA ON CREATING SPECIAL REGISTRATION PROCESS FOR REMOTE PRESCRIBING OF CONTROLLED SUBSTANCES

by ATA Action | Sep 6, 2023 | Press Releases

In response to DEA listening session scheduled for next week regarding updating proposed rules on telehealth WASHINGTON, DC, SEPTEMBER 6, 2023 – ATA Action officially submitted comprehensive recommendations to the Drug Enforcement Administration (DEA) around...

ATA AND ATA ACTION SUBMIT DETAILED COMMENTS IN RESPONSE TO THE CMS CY2024 PHYSICIAN FEE SCHEDULE PROPOSED RULE

by ATA Action | Aug 29, 2023 | Press Releases

WASHINGTON, DC, AUGUST 29, 2023 — The American Telemedicine Association (ATA) and ATA Action submitted comments in response to the Centers for Medicare & Medicaid Services (CMS) CY2024 Physician Fee Schedule (PFS) proposed policy changes for Medicare payments...

TELEHEALTH WINS REPRIEVE: ATA AND ATA ACTION COMMEND DEA AND SAMHSA FOR EXTENSION OF FLEXIBILITIES FOR REMOTE PRESCRIBING OF CONTROLLED SUBSTANCES

by ATA Action | May 9, 2023 | Press Releases

WASHINGTON, DC, MAY 9, 2023 – The American Telemedicine Association (ATA) and ATA Action issued the following statement in response to the Drug Enforcement Administration’s (DEA) and Substance Abuse and Mental Health Services Administration’s (SAMHSA) temporary...

ATA ACTION SUBMITS COMPREHENSIVE RECOMMENDATIONS TO DEA ON PROPOSED RULES REGARDING REMOTE PRESCRIBING OF CONTROLLED SUBSTANCES

by ATA Action | Mar 30, 2023 | Press Releases

WASHINGTON, DC, MARCH 29, 2023 – ATA Action officially submitted comprehensive comments regarding the Drug Enforcement Administration (DEA)’s proposed rules regarding the remote prescribing of controlled substances. In two letters to the DEA, ATA Action outlined...